Antibiotic non-susceptibility among Streptococcus pneumoniae and Haemophilus influenzae isolates identified in African cohorts: A meta-analysis of three decades of published studies

International Journal of Antimicrobial Agents

Volumn 42, Issue 6, 2013, Pages 482-491

  Ginsburg, Amy Sarah ^a   Tinkham, Laura ^b   Riley, Katherine ^b   Kay, Noa A ^c   Klugman, Keith P ^d,e   Gill, Christopher J ^b  

^a PATH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e Department of Global Health ^*  (United States)

Author keywords

Africa; Antibiotic non susceptibility; Haemophilus influenzae; Pneumonia; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAMASE; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIFAMOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; TETRACYCLINE;

AFRICA; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CENTRAL NERVOUS SYSTEM INFECTION; COMMUNITY ACQUIRED PNEUMONIA; ENZYME SYNTHESIS; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; META ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE; TIME SERIES ANALYSIS;

AFRICA; ANTIBIOTIC NON-SUSCEPTIBILITY; HAEMOPHILUS INFLUENZAE; PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

AFRICA; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 84889102288     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.08.012     Document Type: Short Survey

References (35)

1. World Health Organization Recommendations for management of common childhood conditions: newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care 2012 WHO Geneva, Switzerland
2. J.P. Lynch 3rd, and G.G. Zhanel Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention Semin Respir Crit Care Med 30 2009 189 209
3. I.N. Okeke, R. Laxminarayan, Z.A. Bhutta, A.G. Duse, P. Jenkins, and T.F. O'Brien Antimicrobial resistance in developing countries. Part I: recent trends and current status Lancet Infect Dis 5 2005 481 493
4. I. Trehan, R.E. Amthor, K. Maleta, and M.J. Manary Evaluation of the routine use of amoxicillin as part of the home-based treatment of severe acute malnutrition Trop Med Int Health 15 2010 1022 1028
5. J.P. Lynch 3rd, and G.G. Zhanel Streptococcus pneumoniae: does antimicrobial resistance matter? Semin Respir Crit Care Med 30 2009 210 238
6. K.P. Klugman Clinical impact of antibiotic resistance in respiratory tract infections Int J Antimicrob Agents 29 Suppl. 1 2007 S6 S10
7. L. Ambroggio, L.P. Tabb, T. O'Meara, S. Sheffler-Collins, K.L. McGowan, and S.S. Shah Influence of antibiotic susceptibility patterns on empiric antibiotic prescribing for children hospitalized with community-acquired pneumonia Pediatr Infect Dis J 31 2012 331 336
8. A. Leiberman, E. Leibovitz, L. Piglansky, S. Raiz, J. Press, and P. Yagupsky Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media Pediatr Infect Dis J 20 2001 260 264
9. W.L. Straus, S.A. Qazi, Z. Kundi, N.K. Nomani, and B. Schwartz Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group Lancet 352 1998 270 274
10. M.J. Neidell, B. Cohen, Y. Furuya, J. Hill, C.Y. Jeon, and S. Glied Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms Clin Infect Dis 55 2012 807 815
11. United Nations Children's Fund (UNICEF) Pneumonia and diarrhoea: tackling the deadliest diseases for the world's poorest children 2012 UNICEF New York, NY
12. C. Chuang-Stein, and D.M. Tong Multiple comparisons procedures for comparing several treatments with a control based on binary data Stat Med 14 1995 2509 2522
13. G. Rucker, G. Schwarzer, J. Carpenter, and I. Olkin Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells Stat Med 28 2009 721 738
14. S.H. Kim, J.H. Song, D.R. Chung, V. Thamlikitkul, Y. Yang, and H. Wang Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study Antimicrob Agents Chemother 56 2012 1418 1426
15. E. Castaneda, C.I. Agudelo, M. Regueira, A. Corso, M.C. Brandileone, and A.P. Brandao Laboratory-based surveillance of Streptococcus pneumoniae invasive disease in children in 10 Latin American countries: a SIREVA II project, 2000-2005 Pediatr Infect Dis J 28 2009 e265 e270
16. European Centre for Disease Prevention and Control Surveillance of invasive pneumococcal disease in Europe 2010 2012 ECDC Stockholm, Sweden
17. US Centers for Disease Control and Prevention Active Bacterial Core Surveillance (ABCs), Emerging Infections Program Network. ABCs report: Streptococcus pneumoniae 2011 2013 CDC Atlanta, GA
18. P. Crowther-Gibson, C. Cohen, K.P. Klugman, L. de Gouveia, and A. von Gottberg Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008 Antimicrob Agents Chemother 56 2012 5088 5095
19. M.P. Weinstein, K.P. Klugman, and R.N. Jones Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance Clin Infect Dis 48 2009 1596 1600
20. G.O. Akpede, O. Adeyemi, A.A. Abba, and R.M. Sykes Pattern and antibiotic susceptibility of bacteria in pyogenic meningitis in a children's emergency room population in Maiduguri, Nigeria, 1988-1992 Acta Paediatr 83 1994 719 723
21. L. Muhe, and K.P. Klugman Pneumococcal and Haemophilus influenzae meningitis in a children's hospital in Ethiopia: serotypes and susceptibility patterns Trop Med Int Health 4 1999 421 427
22. F.E. Emele Etiologic spectrum and pattern of antimicrobial drug susceptibility in bacterial meningitis in Sokoto, Nigeria Acta Paediatr 89 2000 942 946
23. D.J. Hoban, G.V. Doern, A.C. Fluit, M. Roussel-Delvallez, and R.N. Jones Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999 Clin Infect Dis 32 Suppl. 2 2001 S81 S93
24. E.M. Molyneux, A.L. Walsh, H. Forsyth, M. Tembo, J. Mwenechanya, and K. Kayira Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial Lancet 360 2002 211 218
25. T. Duke, A. Michael, D. Mokela, T. Wal, and J. Reeder Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries? Arch Dis Child 88 2003 536 539
26. M.O. Wasfy, G. Pimentel, M. Abdel-Maksoud, K.L. Russell, C.P. Barrozo, and J.D. Klena Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998-2003 J Antimicrob Chemother 55 2005 958 964
27. K. Prasad, A. Kumar, P.K. Gupta, and T. Singhal Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis Cochrane Database Syst Rev 2007 CD001832
28. W.P. Hausdorff, D.R. Feikin, and K.P. Klugman Epidemiological differences among pneumococcal serotypes Lancet Infect Dis 5 2005 83 93
29. H.M. Soeters, A. von Gottberg, C. Cohen, V. Quan, and K.P. Klugman Trimethoprim-sulfamethoxazole prophylaxis and antibiotic nonsusceptibility in invasive pneumococcal disease Antimicrob Agents Chemother 56 2012 1602 1605
30. C.A. Widdowson, P.V. Adrian, and K.P. Klugman Acquisition of chloramphenicol resistance by the linearization and integration of the entire staphylococcal plasmid pC194 into the chromosome of Streptococcus pneumoniae Antimicrob Agents Chemother 44 2000 393 395
31. L. Aguilar, M.J. Giménez, C. Garcia-Rey, and J.E. Martín New strategies to overcome antimicrobial resistance in Streptococcus pneumoniae with β-lactam antibiotics J Antimicrob Chemother 50 Suppl. S2 2002 93 100
32. F. Baquero, G. Baquero-Artigao, R. Cantón, and C. García-Rey Antibiotic consumption and resistance selection in Streptococcus pneumoniae J Antimicrob Chemother 50 Suppl. S2 2002 27 37
33. K.P. Klugman The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis J Antimicrob Chemother 38 Suppl. A 1996 133 140
34. A. Bari, S. Sadruddin, A. Khan, I. Khan, I.A. Lehri, and W.B. Macleod Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial Lancet 378 2011 1796 1803
35. S. Soofi, S. Ahmed, M.P. Fox, W.B. MacLeod, D.M. Thea, and S.A. Qazi Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial Lancet 379 2012 729 737